Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 1
2005 7
2006 11
2007 2
2008 8
2009 10
2010 6
2011 9
2012 4
2013 8
2014 10
2015 10
2016 15
2017 4
2018 2
2019 7
2020 7
2021 16
2022 14
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, Ohsawa S, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Jpn J Ophthalmol. 2023 May;67(3):264-279. doi: 10.1007/s10384-023-00979-8. Epub 2023 Mar 10. Jpn J Ophthalmol. 2023. PMID: 36897413 Free PMC article. Clinical Trial.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2023 Dec 28:S0161-6420(23)00933-8. doi: 10.1016/j.ophtha.2023.12.026. Online ahead of print. Ophthalmology. 2023. PMID: 38158159 Free article.
Diagnostic Challenges in Inflammatory Choroidal Neovascularization.
Karska-Basta I, Pociej-Marciak W, Żuber-Łaskawiec K, Markiewicz A, Chrząszcz M, Romanowska-Dixon B, Kubicka-Trząska A. Karska-Basta I, et al. Among authors: romanowska dixon b. Medicina (Kaunas). 2024 Mar 12;60(3):465. doi: 10.3390/medicina60030465. Medicina (Kaunas). 2024. PMID: 38541191 Free PMC article. Review.
[Pregnancy and the eye].
Kubicka-Trzaska A, Karska-Basta I, Kobylarz J, Romanowska-Dixon B. Kubicka-Trzaska A, et al. Among authors: romanowska dixon b. Klin Oczna. 2008;110(10-12):401-4. Klin Oczna. 2008. PMID: 19195176 Review. Polish.
Non-malignant uveitis masquerade syndromes.
Kubicka-Trzaska A, Romanowska-Dixon B. Kubicka-Trzaska A, et al. Among authors: romanowska dixon b. Klin Oczna. 2008;110(4-6):203-6. Klin Oczna. 2008. PMID: 18655463 Review.
Malignant uveitis masquerade syndromes.
Kubicka-Trzaska A, Romanowska-Dixon B. Kubicka-Trzaska A, et al. Among authors: romanowska dixon b. Klin Oczna. 2008;110(4-6):199-202. Klin Oczna. 2008. PMID: 18655462 Review.
[Cesarean section and eye disorders].
Karska-Basta I, Tarasiewicz M, Kubicka-Trząska A, Miniewicz J, Romanowska-Dixon B. Karska-Basta I, et al. Among authors: romanowska dixon b. Ginekol Pol. 2016;87(3):217-21. doi: 10.17772/gp/61752. Ginekol Pol. 2016. PMID: 27306132 Free article. Review. Polish.
Diagnostic Algorithm for Conjunctival Melanocytic Lesions.
Dębicka-Kumela M, Romanowska-Dixon B, Karska-Basta I, Kowal J, Pociej-Marciak W, Markiewicz A. Dębicka-Kumela M, et al. Among authors: romanowska dixon b. Anticancer Res. 2021 Jun;41(6):3161-3167. doi: 10.21873/anticanres.15102. Anticancer Res. 2021. PMID: 34083311
165 results